Braun-Bostich & Associates’s CVS Health CVS Stock Holding History

Braun-Bostich & Associates’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,268	Closed	-$191K	–	96
2020 Q3	$191K	Sell	3,268 -3,274	-50%	-$204K	0.19%	92
2020 Q2	$425K	Hold	6,542	–	–	0.41%	45
2020 Q1	$382K	Buy	6,542 +6,098	+1,373%	+$407K	0.49%	47
2019 Q4	$33K	Sell	444 -6,010	-93%	-$422K	0.03%	156
2019 Q3	$407K	Buy	6,454 +846	+15%	+$50.1K	0.47%	43
2019 Q2	$306K	Buy	5,608 +2,342	+72%	+$126K	0.32%	63
2019 Q1	$176K	Buy	3,266 +3,016	+1,206%	+$186K	0.18%	110
2018 Q4	$16K	Hold	250	–	–	0.02%	239
2018 Q3	$20K	Hold	250	–	–	0.02%	233
2018 Q2	$16K	Hold	250	–	–	0.02%	231
2018 Q1	$16K	Hold	250	–	–	0.01%	233
2017 Q4	$18K	Buy	+250	New	+$18.2K	0.02%	227

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Braun-Bostich & Associates's CVS Position: Q4 2020 in Review

Braun-Bostich & Associates sold out of CVS Health (CVS) in Q4 2020, closing a stake of 3,268 shares — an estimated $191K sold.

Braun-Bostich & Associates first reported a position in CVS in Q4 2017 and held it in 12 quarters. The position peaked at $425K in Q2 2020. 1,972 funds tracked by Wall St. Rank hold CVS as of Q4 2020.

Braun-Bostich & Associates reported no remaining CVS Health position as of Q4 2020 after selling out during the quarter.
Braun-Bostich & Associates sold 3,268 CVS Health shares in Q4 2020, an estimated $191K.
Braun-Bostich & Associates first reported a position in CVS Health in Q4 2017 and held it in 12 quarters.
Braun-Bostich & Associates's CVS Health position peaked at $425K in Q2 2020.
1,972 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.

Based on Braun-Bostich & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.